7 Biotech Stocks to Buy for a Post-Pandemic World

Apr 3, 2020

7 Biotech Stocks to Buy for a Post-Pandemic World

Posted by Genevieve Klien in category: biotech/medical

Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics.

Leave a reply

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $594,573.68
BITCOIN ENDOWMENT: $7,245,647.24
A-PRIZE: $30,013.00
NANOSHIELD: $17,018.00
X-RISKS NETWORK: $3,108.00
AISHIELD: $4,112.00

LIFEBOAT NEWS: 3,016 SUBSCRIBERS
GETAS ALERTS: 435 SUBSCRIBERS
BLOG: 48,464 POSTS
BOARDS: 2,842 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 8,341 MEMBERS
LINKEDIN: 1,983 MEMBERS
TWITTER FEED: 33,526 MEMBERS
FIGHT AIDS: 3 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 44 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 3,923
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2020 Lifeboat Foundation